IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B.

Details

Language :

English

ISSN :

2471254X

Volume :

7

Issue :

12

Database :

Complementary Index

Journal :

Hepatology Communications

Publication Type :

Academic Journal

Accession number :

174776945

Full Text :

https://doi.org/10.1097/HC9.0000000000000337